Home   Our Team   Certifications   Customers   Careers   Contact  
 
             
     
Nextar is Israel's only single-point source for all your pharmaceutical product development needs
     
Nextar Ltd. represents Israel's first fully integrated one-stop-shop contract development and manufacturing services company. Nextar provides local biotech, pharma and medical device firms with a full range of custom chemical synthesis, pharmaceutical R&D, formulation development, clinical GMP manufacturing and GLP analytical services. Nextar (Aminolab Pharma)  was established in 2007, following the acquisition of Pharmos' GMP accredited facilities by Aminolab Ltd. Centrally located in the Weizmann Science Park in Ness Ziona, Nextar is housed in more than 1400 m2 state-of-the-art facilities equipped with cutting edge technologies. The company is staffed by highly qualified professionals with extensive experience in developing drug products from early stage through clinical development, up to launch and commercial supply
You are welcome to view our home made movie in the link below and get a glance to our state of the art facility. Enjoy.
http://www.youtube.com/embed/Gvsr6dLDxFs?rel=0

News


Nextar has completed the integration of a new Ion-exchange chromatograph.
The new device allows the separation of ions and polar molecules based on their charge. It can be used for almost any kind of charged molecule including large proteins, small nucleotides and amino acids (November 2011)
A new service - QP release of imported pharmaceutical batches
Following the ministry of health new regulation, as of April 2011, the release of imported batches manufactured in a country that is not accredited by the International Laboratory Accreditation Cooperation, is under the responsibility of the importer. The batches must be tested and released by a GMP laboratory in an accredited country. Nextar invites all importers to use our QP and Analytical services.
A new Corona Charged Aerosol Detector (CAD) for HPLC
Nextar has completed the integration of a novel universal HPLC detector, the Corona Charged Aerosol Detector (CAD) and has successfully completed the validation of an analytical method for assay and IDD of phospholipids. Based on a unique, innovative detection method, the Corona detector is a robust universal detector with sensitivity that is similar and often better than ELSD. This makes it ideal for determination of low-level impurities, studies of leachables and extractables, or just assay of analytes that are not suitable for UV detection (e.g. phospholipids, carbohydrates etc.).
 
       
  Design - Studiommoza

Powered by Team-AT